Daniel J Johnson, MD | |
251 E Huron St, Chicago, IL 60611-2908 | |
(312) 926-2000 | |
Not Available |
Full Name | Daniel J Johnson |
---|---|
Gender | Male |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 251 E Huron St, Chicago, Illinois |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033650346 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | 125.069937 (Illinois) | Secondary |
390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Daniel J Johnson, MD 251 E Huron St, Chicago, IL 60611-2908 Ph: (312) 926-2000 | Daniel J Johnson, MD 251 E Huron St, Chicago, IL 60611-2908 Ph: (312) 926-2000 |
News Archive
Novartis announced today that the US Food and Drug Administration has approved an expanded use for Promacta to include children 1 year of age and older with chronic immune thrombocytopenia who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy.
Scientists from Far Eastern Federal University in cooperation with colleagues from Blokhin Russian Cancer Research Center, Switzerland, and Sweden for the first time studied proteins, which constitute WNT signaling pathway of the cancer stem cells of glioblastoma multiforme (GBM CD133+ CSCs), one of the most aggressive brain tumors.
The New York Times and Wall Street Journal report on how Capitol Hill lawmakers and their staffs are having a very different experience choosing coverage than most of their constituents.
In a two-day conference organised in collaboration between the Maltese Presidency of the Council of the European Union and ECDC, HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
› Verified 7 days ago